HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

Triethylamine → 1-(4-(Oxazol-2-yl)phenyl)piperidin-3-yl methanesulfonate

HRID 2409886
Notes
Print preview

Reaction equation

HRID 2409886 reaction equation
[O:1]1[CH:5]=[CH:4][N:3]=[C:2]1[C:6]1[CH:11]=[CH:10][C:9]([N:12]2[CH2:17][CH2:16][CH2:15][CH:14]([OH:18])[CH2:13]2)=[CH:8][CH:7]=1.[S:19](Cl)([CH3:22])(=[O:21])=[O:20].CCN(CC)CC>C(Cl)Cl>[CH3:22][S:19]([O:18][CH:14]1[CH2:15][CH2:16][CH2:17][N:12]([C:9]2[CH:8]=[CH:7][C:6]([C:2]3[O:1][CH:5]=[CH:4][N:3]=3)=[CH:11][CH:10]=2)[CH2:13]1)(=[O:21])=[O:20]
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

5

Reactant 3

HCID 8471TriethylamineHCID 31297Methanesulfonyl chlorideHCID 712269401-(4-(Oxazol-2-yl)phenyl)piperidin-3-ol

Product 1

HCID 866902081-(4-(Oxazol-2-yl)phenyl)piperidin-3-yl methanesulfonate

Reagents, catalysts & solvents 1

HCID 6344DichloromethaneSolvent

Conditions

Temperature
0 °C

Procedure

To a solution of 1-(4-(oxazol-2-yl)phenyl)piperidin-3-ol (85 mg, 0.348 mmol) in CH2Cl2 (2 mL) at 0° C. was added dropwise mesyl chloride (0.033 mL, 0.418 mmol), followed by Et3N (0.058 mL, 0.418 mmol). The reaction was stirred at 0° C. for 5 min, and then at rt for 30 min. After this time, HPLC and LC/MS showed that the desired product formed and there was no starting material remaining. The reaction mixture was concentrated. The residue was dissolved in EtOAc, washed with water, saturated aqueous NaHCO3, and saturated aqueous NaCl. The organic layer was dried over Na2SO4, filtered and concentrated to give the desired product 1-(4-(oxazol-2-yl)phenyl)piperidin-3-yl methanesulfonate (110 mg, 0.341 mmol, 98% yield) as an off-white foam. Anal. Calcd. for C15H18N2O4S m/z 322.3, found: 323.1 (M+H)+.

Workup

  1. waitat rt for 30 min

Sources & evidence

ORD record
ord-c81eca5354394af88b4d62d839ffb9bf
Source dataset
uspto-grants-2014_08
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08815909B2

Reaction notes

Loading…

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes